AC
BSX icon

ASB Consultores’s Boston Scientific BSX Stock Holding History

ASB Consultores’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,408
Closed -$293K – 149
2023
Q2 		$293K Sell
5,408
-1,216
-18% -$63.5K 0.14% 135
2023
Q1 		$331K Buy
+6,624
New +$312K 0.13% 120

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ASB Consultores's BSX Position: Q3 2023 in Review

ASB Consultores sold out of Boston Scientific (BSX) in Q3 2023, closing a stake of 5,408 shares — an estimated $293K sold.

ASB Consultores first reported a position in BSX in Q1 2023 and held it in 2 quarters. The position peaked at $331K in Q1 2023. 1,056 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

  • ASB Consultores reported no remaining Boston Scientific position as of Q3 2023 after selling out during the quarter.
  • ASB Consultores sold 5,408 Boston Scientific shares in Q3 2023, an estimated $293K.
  • ASB Consultores first reported a position in Boston Scientific in Q1 2023 and held it in 2 quarters.
  • ASB Consultores's Boston Scientific position peaked at $331K in Q1 2023.
  • 1,056 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on ASB Consultores's 13F filing for Q3 2023, filed 28 Nov 2023.